Prevalence, Treatment Patterns, and Characteristics of US Adults with Confirmed or at Risk for Growth Hormone Deficiency
Our findings report US prevalence of adult GHD and suggest that adult GHD is commonly underdiagnosed in the US. Factors contributing to low rates of adult GHD diagnosis and treatment warrant further research.
Authors
- Andrew R. Hoffman (ORCID: https://orcid.org/0000-0002-0145-1917)
- Jennifer Cheng (ORCID: https://orcid.org/0000-0001-8458-619X)
- Isabelle Winer (ORCID: https://orcid.org/0000-0002-7294-8162)
- Allison Komirenko (ORCID: https://orcid.org/0000-0001-8844-2804)
- Janna Manjelievskaia (ORCID: https://orcid.org/0000-0002-8293-512X)
- Jessamine Winer‐Jones (ORCID: https://orcid.org/0000-0002-6412-4139)
- Alden Smith (ORCID: https://orcid.org/0000-0003-1582-534X)
- Machaon Bonafede (ORCID: https://orcid.org/0000-0001-6330-6718)
- Subhara Raveendran (ORCID: https://orcid.org/0000-0003-0151-6298)
- Paul Miner
Institutions
- Ascendis Pharma (Denmark) (DK)
- Stanford University (US)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1007/s12325-025-03188-6
- Citations
- 6
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 7.77